外泌体在脓毒症免疫麻痹机制中的研究进展
Research Progress of Exosomes in the Mechanism of Immunosuppression in Sepsis
DOI: 10.12677/acm.2024.1492570, PDF,   
作者: 向俊洁:南华大学衡阳医学院,湖南 衡阳;周建亮*:南华大学怀化临床学院,湖南 怀化
关键词: 外泌体免疫麻痹脓毒症程序性死亡受体1嗜中性粒细胞细胞外陷阱Exosomes Immune Paralysis Sepsis Programmed Death Receptor 1 (PD-1) Neutrophil Extracellular Trap (NET)
摘要: 脓毒症(sepsis)作为一种在重症监护病房中常见的高危疾病,其特征是由于宿主体内感染引发的免疫反应失衡,进而导致生命威胁性的多器官功能衰竭。免疫系统的调控紊乱是脓毒症发病的核心机制,而在疾病进程中,免疫细胞的凋亡加速和炎症因子的异常释放所引发的免疫功能抑制,是造成多数患者死亡的重要原因。近年来,外泌体在脓毒症中的角色受到了广泛关注,特别是在免疫调节方面的作用,可在细胞间传递信息,影响宿主的免疫响应。在脓毒症中,外泌体可能通过携带特定的信号分子影响免疫细胞的功能,从而在免疫麻痹中起到一定的作用。免疫功能监测与免疫治疗在肿瘤领域成为研究的热点并取得一定成果,脓毒症同样涉及免疫麻痹,但其具体机制值得进一步探究。本文就脓毒症免疫麻痹机制中外泌体可能通过的两个机制的研究进展进行综述。
Abstract: Sepsis is a common high-risk disease in intensive care units. It is characterized by an imbalance in the immune response caused by infection in the host, which in turn leads to life-threatening multiple organ failure. The disorder of immune system regulation is the core mechanism of sepsis pathogenesis. In the disease process, the accelerated apoptosis of immune cells and the abnormal release of inflammatory factors causing immunosuppression are important reasons for the death of most patients. In recent years, the role of exosomes in sepsis has received extensive attention, especially their role in immune regulation. They can transmit information between cells and affect the host’s immune response. In sepsis, exosomes may affect the function of immune cells by carrying specific signal molecules, thus playing a certain role in immune paralysis. Immune function monitoring and immunotherapy have become research hotspots in the field of tumors and have achieved certain results. Sepsis also involves immune paralysis, but its specific mechanism is worthy of further exploration. This article reviews the research progress of two possible mechanisms through which exosomes may act in the mechanism of immunosuppression in sepsis.
文章引用:向俊洁, 周建亮. 外泌体在脓毒症免疫麻痹机制中的研究进展[J]. 临床医学进展, 2024, 14(9): 1086-1092. https://doi.org/10.12677/acm.2024.1492570

参考文献

[1] Singer, M., Deutschman, C.S., Seymour, C.W., Shankar-Hari, M., Annane, D., Bauer, M., et al. (2016) The Third International Consensus Definitions for Sepsis and Septic Shock (sepsis-3). JAMA, 315, 801-810. [Google Scholar] [CrossRef] [PubMed]
[2] Font, M.D., Thyagarajan, B. and Khanna, A.K. (2020) Sepsis and Septic Shock—Basics of Diagnosis, Pathophysiology and Clinical Decision Making. Medical Clinics of North America, 104, 573-585. [Google Scholar] [CrossRef] [PubMed]
[3] Weng, L., Zeng, X., Yin, P., Wang, L., Wang, C., Jiang, W., et al. (2018) Sepsis-Related Mortality in China: A Descriptive Analysis. Intensive Care Medicine, 44, 1071-1080. [Google Scholar] [CrossRef] [PubMed]
[4] Xie, J., Wang, H., Kang, Y., Zhou, L., Liu, Z., Qin, B., et al. (2020) The Epidemiology of Sepsis in Chinese Icus: A National Cross-Sectional Survey. Critical Care Medicine, 48, e209-e218. [Google Scholar] [CrossRef] [PubMed]
[5] 翟昭, 王楠, 张宇晨, 等. 脓毒症的免疫病理机制及诊断和预后预测生物标志物研究进展[J]. 山东医药, 2022, 62(21): 108-112.
[6] Venet, F. and Monneret, G. (2017) Advances in the Understanding and Treatment of Sepsis-Induced Immunosuppression. Nature Reviews Nephrology, 14, 121-137. [Google Scholar] [CrossRef] [PubMed]
[7] Kalluri, R. and LeBleu, V.S. (2020) The Biology, Function, and Biomedical Applications of Exosomes. Science, 367, eaau6977. [Google Scholar] [CrossRef] [PubMed]
[8] Murao, A., Brenner, M., Aziz, M. and Wang, P. (2020) Exosomes in Sepsis. Frontiers in Immunology, 11, Article No. 2140. [Google Scholar] [CrossRef] [PubMed]
[9] Familtseva, A., Jeremic, N. and Tyagi, S.C. (2019) Exosomes: Cell-Created Drug Delivery Systems. Molecular and Cellular Biochemistry, 459, 1-6. [Google Scholar] [CrossRef] [PubMed]
[10] Kimiz-Gebologlu, I. and Oncel, S.S. (2022) Exosomes: Large-Scale Production, Isolation, Drug Loading Efficiency, and Biodistribution and Uptake. Journal of Controlled Release, 347, 533-543. [Google Scholar] [CrossRef] [PubMed]
[11] Pegtel, D.M. and Gould, S.J. (2019) Exosomes. Annual Review of Biochemistry, 88, 487-514. [Google Scholar] [CrossRef] [PubMed]
[12] 韩丹. 外泌体在脓毒症诊疗作用中的研究进展[J]. 医学信息, 2023, 36(5): 173-176.
[13] Zhou, Y., Li, P., Goodwin, A.J., Cook, J.A., Halushka, P.V., Chang, E., et al. (2018) Exosomes from Endothelial Progenitor Cells Improve the Outcome of a Murine Model of Sepsis. Molecular Therapy, 26, 1375-1384. [Google Scholar] [CrossRef] [PubMed]
[14] Choi, H., Kim, Y., Mirzaaghasi, A., Heo, J., Kim, Y.N., Shin, J.H., et al. (2020) Exosome-Based Delivery of Super-Repressor Iκbα Relieves Sepsis-Associated Organ Damage and Mortality. Science Advances, 6, eaaz6980. [Google Scholar] [CrossRef] [PubMed]
[15] Liu, F., Peng, W., Chen, J., Xu, Z., Jiang, R., Shao, Q., et al. (2021) Exosomes Derived from Alveolar Epithelial Cells Promote Alveolar Macrophage Activation Mediated by Mir-92a-3p in Sepsis-Induced Acute Lung Injury. Frontiers in Cellular and Infection Microbiology, 11, Article ID: 646546. [Google Scholar] [CrossRef] [PubMed]
[16] Im, Y., Yoo, H., Lee, J.Y., Park, J., Suh, G.Y. and Jeon, K. (2020) Association of Plasma Exosomes with Severity of Organ Failure and Mortality in Patients with Sepsis. Journal of Cellular and Molecular Medicine, 24, 9439-9445. [Google Scholar] [CrossRef] [PubMed]
[17] Cao, C., Yu, M. and Chai, Y. (2019) Pathological Alteration and Therapeutic Implications of Sepsis-Induced Immune Cell Apoptosis. Cell Death & Disease, 10, Article No. 782. [Google Scholar] [CrossRef] [PubMed]
[18] Nedeva, C., Menassa, J. and Puthalakath, H. (2019) Sepsis: Inflammation Is a Necessary Evil. Frontiers in Cell and Developmental Biology, 7, Article No. 108. [Google Scholar] [CrossRef] [PubMed]
[19] Drewry, A.M., Samra, N., Skrupky, L.P., Fuller, B.M., Compton, S.M. and Hotchkiss, R.S. (2014) Persistent Lymphopenia after Diagnosis of Sepsis Predicts Mortality. Shock, 42, 383-391. [Google Scholar] [CrossRef] [PubMed]
[20] Francois, B., Jeannet, R., Daix, T., Walton, A.H., Shotwell, M.S., Unsinger, J., et al. (2018) Interleukin-7 Restores Lymphocytes in Septic Shock: The IRIS-7 Randomized Clinical Trial. JCI Insight, 3, e98960. [Google Scholar] [CrossRef] [PubMed]
[21] Keir, M.E., Butte, M.J., Freeman, G.J. and Sharpe, A.H. (2008) PD-1 and Its Ligands in Tolerance and Immunity. Annual Review of Immunology, 26, 677-704. [Google Scholar] [CrossRef] [PubMed]
[22] Hassan, S.S., Akram, M., King, E.C., Dockrell, H.M. and Cliff, J.M. (2015) PD-1, PD-L1 and PD-L2 Gene Expression on T-Cells and Natural Killer Cells Declines in Conjunction with a Reduction in PD-1 Protein during the Intensive Phase of Tuberculosis Treatment. PLOS ONE, 10, e0137646. [Google Scholar] [CrossRef] [PubMed]
[23] Li, C., Wang, W., Xie, S., Ma, W., Fan, Q., Chen, Y., et al. (2021) The Programmed Cell Death of Macrophages, Endothelial Cells, and Tubular Epithelial Cells in Sepsis-AKI. Frontiers in Medicine, 8, Article ID: 796724. [Google Scholar] [CrossRef] [PubMed]
[24] Liu, J., Chen, Z., Li, Y., Zhao, W., Wu, J. and Zhang, Z. (2021) PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy. Frontiers in Pharmacology, 12, Article ID: 731798. [Google Scholar] [CrossRef] [PubMed]
[25] Nakamori, Y., Park, E.J. and Shimaoka, M. (2021) Immune Deregulation in Sepsis and Septic Shock: Reversing Immune Paralysis by Targeting PD-1/PD-L1 Pathway. Frontiers in Immunology, 11, Article ID: 624279. [Google Scholar] [CrossRef] [PubMed]
[26] Derigs, M., Heers, H., Lingelbach, S., Hofmann, R. and Hänze, J. (2022) Soluble PD-L1 in Blood Correlates Positively with Neutrophil and Negatively with Lymphocyte mRNA Markers and Implies Adverse Sepsis Outcome. Immunologic Research, 70, 698-707. [Google Scholar] [CrossRef] [PubMed]
[27] Loacker, L., Egger, A., Fux, V., Bellmann-Weiler, R., Weiss, G., Griesmacher, A., et al. (2023) Serum Spd-L1 Levels Are Elevated in Patients with Viral Diseases, Bacterial Sepsis or in Patients with Impaired Renal Function Compared to Healthy Blood Donors. Clinical Chemistry and Laboratory Medicine (CCLM), 61, 2248-2255. [Google Scholar] [CrossRef] [PubMed]
[28] Jia, L., Liu, K., Fei, T., Liu, Q., Zhao, X., Hou, L., et al. (2021) Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Inhibitors Exert Antiapoptosis and Antiinflammatory Activity in Lipopolysaccharide Stimulated Murine Alveolar Macrophages. Experimental and Therapeutic Medicine, 21, Article No. 400. [Google Scholar] [CrossRef] [PubMed]
[29] Zhang, X., Ji, W., Deng, X. and Bo, L. (2023) High-Dose Ascorbic Acid Potentiates Immune Modulation through STAT1 Phosphorylation Inhibition and Negative Regulation of PD-L1 in Experimental Sepsis. Inflammopharmacology, 32, 537-550. [Google Scholar] [CrossRef] [PubMed]
[30] Yuan, L., Wang, Y., Chen, Y., Chen, X., Li, S. and Liu, X. (2023) Shikonin Inhibits Immune Checkpoint PD-L1 Expression on Macrophage in Sepsis by Modulating Pkm2. International Immunopharmacology, 121, Article ID: 110401. [Google Scholar] [CrossRef] [PubMed]
[31] Monteiro, V.V.S., Reis, J.F., de Souza Gomes, R., Navegantes, K.C. and Monteiro, M.C. (2017) Dual Behavior of Exosomes in Septic Cardiomyopathy. In: Xiao, J. and Cretoiu, S., Eds., Exosomes in Cardiovascular Diseases, Springer Singapore, 101-112. [Google Scholar] [CrossRef] [PubMed]
[32] Poggio, M., Hu, T., Pai, C., Chu, B., Belair, C.D., Chang, A., et al. (2019) Suppression of Exosomal PD-L1 Induces Systemic Anti-Tumor Immunity and Memory. Cell, 177, 414-427.e13. [Google Scholar] [CrossRef] [PubMed]
[33] Kawamoto, E., Masui-Ito, A., Eguchi, A., Soe, Z.Y., Prajuabjinda, O., Darkwah, S., et al. (2019) Integrin and PD-1 Ligand Expression on Circulating Extracellular Vesicles in Systemic Inflammatory Response Syndrome and Sepsis. Shock, 52, 13-22. [Google Scholar] [CrossRef] [PubMed]
[34] Curran, C.S., Busch, L.M., Li, Y., Xizhong, C., Sun, J., Eichacker, P.Q., et al. (2021) Anti-PD-l1 Therapy Does Not Improve Survival in a Murine Model of Lethal Staphylococcus aureus Pneumonia. The Journal of Infectious Diseases, 224, 2073-2084. [Google Scholar] [CrossRef] [PubMed]
[35] Tirlangi, D.P., Kumar, M.P., et al. (2022) Programmed Cell Death-1/Programmed Death-Ligand 1 Expression and Its Association with Mortality among Patients with Sepsis and Hospital-Acquired Infections: Sepsimmune Study. Journal of Infection, 85, e49-e51. [Google Scholar] [CrossRef] [PubMed]
[36] Li, R.H.L. and Tablin, F. (2018) A Comparative Review of Neutrophil Extracellular Traps in Sepsis. Frontiers in Veterinary Science, 5, Article No. 291. [Google Scholar] [CrossRef] [PubMed]
[37] Kaplan, M.J. and Radic, M. (2012) Neutrophil Extracellular Traps: Double-Edged Swords of Innate Immunity. The Journal of Immunology, 189, 2689-2695. [Google Scholar] [CrossRef] [PubMed]
[38] Caudrillier, A., Kessenbrock, K., Gilliss, B.M., Nguyen, J.X., Marques, M.B., Monestier, M., et al. (2012) Platelets Induce Neutrophil Extracellular Traps in Transfusion-Related Acute Lung Injury. Journal of Clinical Investigation, 122, 2661-2671. [Google Scholar] [CrossRef] [PubMed]
[39] Jiao, Y., Li, W., Wang, W., Tong, X., Xia, R., Fan, J., et al. (2020) Platelet-Derived Exosomes Promote Neutrophil Extracellular Trap Formation during Septic Shock. Critical Care, 24, Article No. 380. [Google Scholar] [CrossRef] [PubMed]
[40] Gierlikowska, B., Stachura, A., Gierlikowski, W. and Demkow, U. (2022) The Impact of Cytokines on Neutrophils’ Phagocytosis and NET Formation during Sepsis—A Review. International Journal of Molecular Sciences, 23, Article No. 5076. [Google Scholar] [CrossRef] [PubMed]
[41] Zhang, H., Wang, Y., Onuma, A., He, J., Wang, H., Xia, Y., et al. (2021) Neutrophils Extracellular Traps Inhibition Improves PD-1 Blockade Immunotherapy in Colorectal Cancer. Cancers, 13, Article No. 5333. [Google Scholar] [CrossRef] [PubMed]
[42] Silva, C.M.S., Wanderley, C.W.S., Veras, F.P., Sonego, F., Nascimento, D.C., Gonçalves, A.V., et al. (2021) Gasdermin D Inhibition Prevents Multiple Organ Dysfunction during Sepsis by Blocking NET Formation. Blood, 138, 2702-2713. [Google Scholar] [CrossRef] [PubMed]